Literature DB >> 7461722

Artificial binding of macrophages to syngeneic cells elicits cytostasis but not cytolysis.

S Cabilly, R Gallily.   

Abstract

Artificial binding of mouse peritoneal macrophages to syngeneic embryonic fibroblasts by means of rabbit anti-mouse anti-macrophage serum or Con-canavalin A inhibited the proliferation of syngeneic target cells without destroying them. It is suggested that an intimate membranal contact between macrophages and target cells triggered cytostasis, whereas cytotoxicity requires an additional step of foreign recognition.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7461722      PMCID： PMC1458200     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  18 in total

1.  The capacity of macrophage components to inhibit anti-macrophage serum activity.

Authors:  A J Schroit; B Geiger; R Gallily
Journal:  Eur J Immunol       Date:  1973-06       Impact factor: 5.532

2.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

3.  Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors.

Authors:  R Keller
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

4.  Cytotoxicity of murine peritoneal macrophages in tumour allograft immunity.

Authors:  W Den Otter; R Evans; P Alexander
Journal:  Transplantation       Date:  1972-08       Impact factor: 4.939

5.  Macrophage cytotoxicity factor. A product of in vitro sensitized thymus-dependent cells.

Authors:  M L Lohmann-Matthes; F G Ziegler; H Fischer
Journal:  Eur J Immunol       Date:  1973-01       Impact factor: 5.532

6.  Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum.

Authors:  I Basić; L Milas; D J Grdina; H R Withers
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

7.  Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

Authors:  R P Cleveland; M S Meltzer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

8.  Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

9.  Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

10.  Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.

Authors:  R Evans; P Alexander
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397
View more
  4 in total

1.  Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts.

Authors:  R Gallily; G E Gifford; J Loewenstein
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Non-immunological recognition and killing of xenogeneic cells by macrophages. II. Mechanism of killing.

Authors:  S Cabilly; R Gallily
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

3.  Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.

Authors:  V Schirrmacher; B Appelhans
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

4.  Macrophages induce antibody-dependent cytostasis but not lysis in guinea pig leukaemic cells.

Authors:  A D Lawson; G T Stevenson
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.